| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |